Nociplastic Pain
Original Editor - Kapil Narale
This article or area is currently under construction and may only be partially complete. Please come back soon to see the finished work! (11/08/2023)
Top Contributors - Kapil Narale, Kim Jackson, Ewa Jaraczewska, Candace Goh, Melissa Coetsee and Sehriban Ozmen
IASP Definition[edit | edit source]
Until 2017, pain mechanisms have been divided into “nociceptive pain” and “neuropathic pain”. Since these only include pain from two specific sources, there are a large group of patients without a valid pathophysiological identification for their experience of pain. This pain experienced is neither nociceptive nor neuropathic. Thus, this group comprises people who have neither obvious activation of nociceptors nor neuropathy, but clinical and psychophysical findings suggest altered nociceptive function.
Recommended by the IASP, "Nociplastic Pain is a term used to describe persistent pain that arises from altered nociception, despite no clear evidence of actual or threatened tissue damage causing the activation of peripheral nociceptors, or evidence for disease or lesion of the somatosensory system causing the pain." [1]
Types of conditions that fall under the umbrella of Nociplastic Pain include: fibromyalgia, complex regional pain syndrome, other types of musculoskeletal pain such as chronic low back pain, visceral pain disorders such as irritable bowel syndrome and bladder pain syndrome.
It is seen that there isn't a single term that is fully suitable for describing someone's pain, and the pain experience can overlap between the 3 terms of nociceptive, neuropathic, and nociplastic pain.
Nociplastic Pain is not a diagnosis, but a descriptor of the pain that is being experienced.
Sub Heading 2[edit | edit source]
Sub Heading 3[edit | edit source]
Resources[edit | edit source]
- bulleted list
- x
or
- numbered list
- x
References[edit | edit source]
- ↑ Slater H, Hush J. Pain Terminology: Introduction Of a Third Clinical Descriptor. Pain Terminology. 2018:3:7-8.
